Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

Clinical trial NCT05100069 · RECRUITING

Trial details

NCT number: NCT05100069
Sponsor: Takeda
Status: RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer (NSCLC)

Start date: 2021-11-01
Primary completion: 2030-09-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.